The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis
Open accessAbstract
Analysis of ALS patient iPSC-derived motor neurons indicates that Src/c-Abl inhibitors may have potential for treating ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009) · Nature · doi:10.1038/nature07863 · Cited by 1,814
Self-citationConverging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 2×
“INTRODUCTION Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes progressive loss of motor neurons (1, 2).”
BackgroundFUSAKI, N., BAN, H., NISHIYAMA, A., SAEKI, K., & HASEGAWA, M. (2009) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.85.348 · Cited by 1,411
Identification of a transformation-specific antigen induced by an avian sarcoma virus
BRUGGE, J. S., & ERIKSON, R. L. (1977) · Nature · doi:10.1038/269346a0 · Cited by 888
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
Okita, K., Yamakawa, T., Matsumura, Y., Sato, Y., Amano, N., Watanabe, A., Goshima, N., & Yamanaka, S. (2013) · Stem Cells · doi:10.1002/stem.1293 · Cited by 749
Self-citationKondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
Self-citationStructure and regulation of Src family kinases
Boggon, T. J., & Eck, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1208081 · Cited by 712 · cited 1×
“Further study is needed to identify more specific targets among the Src family including c-Src, Lck, and Lyn (43), and c-Abl.”
BackgroundIntrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons
Wainger, B. J., Kiskinis, E., Mellin, C., Wiskow, O., Han, S. S. W., Sandoe, J., Perez, N. P., Williams, L. A., Lee, S., Boulting, G., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.019 · Cited by 662
Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells
Egawa, N., Kitaoka, S., Tsukita, K., Naitoh, M., Takahashi, K., Yamamoto, T., Adachi, F., Kondo, T., Okita, K., Asaka, I., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004052 · Cited by 549
Self-citationLi, H. L., Fujimoto, N., Sasakawa, N., Shirai, S., Ohkame, T., Sakuma, T., Tanaka, M., Amano, N., Watanabe, A., Sakurai, H., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.10.013 · Cited by 471
Self-citationPathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1
Kiskinis, E., Sandoe, J., Williams, L. A., Boulting, G. L., Moccia, R., Wainger, B. J., Han, S., Peng, T., Thams, S., Mikkilineni, S., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.03.004 · Cited by 441
Role of ABL family kinases in cancer: from leukaemia to solid tumours
Greuber, E. K., Smith-Pearson, P., Wang, J., & Pendergast, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3563 · Cited by 432
Welch, P. (1993) · Cell · doi:10.1016/0092-8674(93)90497-e · Cited by 407
Bilican, B., Serio, A., Barmada, S. J., Nishimura, A. L., Sullivan, G. J., Carrasco, M., Phatnani, H. P., Puddifoot, C. A., Story, D., Fletcher, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202922109 · Cited by 328
Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons
Chen, H., Qian, K., Du, Z., Cao, J., Petersen, A., Liu, H., Blackbourn, L. W., Huang, C.-L., Errigo, A., Yin, Y., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.004 · Cited by 318
Yang, Y. M., Gupta, S. K., Kim, K. J., Powers, B. E., Cerqueira, A., Wainger, B. J., Ngo, H. D., Rosowski, K. A., Schein, P. A., Ackeifi, C. A., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.04.003 · Cited by 305
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K. A., Laird, A. S., Peeters, E., Philips, T., Goris, A., Dubois, B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2901 · Cited by 303
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells
Burkhardt, M. F., Martinez, F. J., Wright, S., Ramos, C., Volfson, D., Mason, M., Garnes, J., Dang, V., Lievers, J., Shoukat-Mumtaz, U., et al. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.07.007 · Cited by 300
Devlin, A.-C., Burr, K., Borooah, S., Foster, J. D., Cleary, E. M., Geti, I., Vallier, L., Shaw, C. E., Chandran, S., & Miles, G. B. (2015) · Nature Communications · doi:10.1038/ncomms6999 · Cited by 295
The anticancer drug imatinib induces cellular autophagy
Ertmer, A., Huber, V, Gilch, S., Yoshimori, T., Erfle, V, Duyster, J., Elsässer, H.-P., & Schätzl, H. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404606 · Cited by 221
Mahul-Mellier, A.-L., Fauvet, B., Gysbers, A., Dikiy, I., Oueslati, A., Georgeon, S., Lamontanara, A. J., Bisquertt, A., Eliezer, D., Masliah, E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt674 · Cited by 219
Mitne-Neto, M., Machado-Costa, M., Marchetto, M. C. N., Bengtson, M. H., Joazeiro, C. A., Tsuda, H., Bellen, H. J., Silva, H. C. A., Oliveira, A. S. B., Lazar, M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr284 · Cited by 214
Fang, Y.-S., Tsai, K.-J., Chang, Y.-J., Kao, P., Woods, R., Kuo, P.-H., Wu, C.-C., Liao, J.-Y., Chou, S.-C., Lin, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5824 · Cited by 211
Functional Properties of Motoneurons Derived from Mouse Embryonic Stem Cells
Miles, G. B., Yohn, D. C., Wichterle, H., Jessell, T. M., Rafuse, V. F., & Brownstone, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1972-04.2004 · Cited by 209
Gros‐Louis, F., Soucy, G., Larivière, R., & Julien, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06683.x · Cited by 188
Self-citationHester, M. E., Murtha, M. J., Song, S., Rao, M., Miranda, C. J., Meyer, K., Tian, J., Boulting, G., Schaffer, D. V., Zhu, M. X., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.135 · Cited by 183
A Computational Model of Motor Neuron Degeneration
Masson, G. L., Przedborski, S., & Abbott, L. F. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.001 · Cited by 176
Ravits, J., Appel, S., Baloh, R. H., Barohn, R., Rix Brooks, B., Elman, L., Floeter, M. K., Henderson, C., Lomen-Hoerth, C., Macklis, J. D., et al. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.778548 · Cited by 169
α-Synuclein Is Phosphorylated by Members of the Src Family of Protein-tyrosine Kinases
Ellis, C. E., Schwartzberg, P. L., Grider, T. L., Fink, D. W., & Nussbaum, R. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010316200 · Cited by 161
Protecting Motor Neurons from Toxic Insult by Antagonism of Adenosine A2a and Trk Receptors
Mojsilovic‐Petrovic, J., Jeong, G., Crocker, A. J., Arneja, A., David, S., Russell, D., & Kalb, R. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1856-06.2006 · Cited by 150
Ito, Y., Pandey, P., Mishra, N. C., Kumar, S., Narula, N., Kharbanda, S. M., Saxena, S. P., & Kufe, D. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6233-6242.2001 · Cited by 141
c-Abl in Neurodegenerative Disease
Schlatterer, S. D., Acker, C. M., & Davies, P. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9588-1 · Cited by 136
Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons
Kim, S., Oceguera-Yañez, F., Sakurai, C., Nakagawa, M., Yamanaka, S., & Woltjen, K. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_251 · Cited by 124
Self-citationBrotherton, T. E., Li, Y., Cooper, D., Gearing, M., Julien, J., Rothstein, J. D., Boylan, K., & Glass, J. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115009109 · Cited by 122
Self-citationTremblay, M. A., Acker, C. M., & Davies, P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1271 · Cited by 113
Of mice and men: Reconciling preclinical ALS mouse studies and human clinical trials
Rothstein, J. D. (2003) · Annals of Neurology · doi:10.1002/ana.10561 · Cited by 89
Fujisawa, T., Homma, K., Yamaguchi, N., Kadowaki, H., Tsuburaya, N., Naguro, I., Matsuzawa, A., Takeda, K., Takahashi, Y., Goto, J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23668 · Cited by 87
Self-citationParkin Plays a Role in Sporadic Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2013) · Neurodegenerative Diseases · doi:10.1159/000354307 · Cited by 85
Altered subcellular distribution of c-Abl in Alzheimer’s disease
Jing, Z., Caltagarone, J., & Bowser, R. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1062 · Cited by 83
Lobsiger, C. S., Boillée, S., Pozniak, C. D., Khan, A. M., McAlonis‐Downes, M., Lewcock, J. W., & Cleveland, D. W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318309110 · Cited by 77
An Update On Dual Src/Abl Inhibitors
Musumeci, F., Schenone, S., Brullo, C., & Botta, M. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.29 · Cited by 57
Matsui, H., Fujimoto, N., Sasakawa, N., Ohinata, Y., Shima, M., Yamanaka, S., Sugimoto, M., & Hotta, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104957 · Cited by 55
Self-citationKatsumata, R., Ishigaki, S., Katsuno, M., Kawai, K., Sone, J., Huang, Z., Adachi, H., Tanaka, F., Urano, F., & Sobue, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046185 · Cited by 50
Fujisawa, T., Takahashi, M., Tsukamoto, Y., Yamaguchi, N., Nakoji, M., Endo, M., Kodaira, H., Hayashi, Y., Nishitoh, H., Naguro, I., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv467 · Cited by 47
Self-citationChen, W., Lonskaya, I., Hebron, M. L., Ibrahim, Z., Olszewski, R. T., Neale, J. H., & Moussa, C. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu211 · Cited by 44
Selective kinase inhibitors as tools for neuroscience research
Martin, K. J., & Arthur, J. S. C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.024 · Cited by 19
Cited by
C9orf72-mediated ALS and FTD: multiple pathways to disease
Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715
Mead, R. J., Shan, N., Reiser, H. J., Marshall, F., & Shaw, P. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00612-2 · Cited by 505
Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent
Fujimori, K., Ishikawa, M., Otomo, A., Atsuta, N., Nakamura, R., Akiyama, T., Hadano, S., Aoki, M., Saya, H., Sobue, G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0140-5 · Cited by 494
Osaki, T., Uzel, S. G. M., & Kamm, R. D. (2018) · Science Advances · doi:10.1126/sciadv.aat5847 · Cited by 421
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
Self-citation
Metadata
- Authors
- Imamura, K., Izumi, Y., Watanabe, A., Tsukita, K., Woltjen, K., Yamamoto, T., Hotta, A., Kondo, T., Kitaoka, S., Ohta, A., Tanaka, A., Watanabe, D., Morita, M., Takuma, H., Tamaoka, A., Kunath, T., Wray, S., Furuya, H., Era, T., Makioka, K., Okamoto, K., Fujisawa, T., Nishitoh, H., Homma, K., Ichijo, H., Julien, J.-P., Obata, N., Hosokawa, M., Akiyama, H., Kaneko, S., Ayaki, T., Ito, H., Kaji, R., Takahashi, R., Yamanaka, S., & Inoue, H.
- Venue
- Science Translational Medicine
- Published
- 2017-05-24
- Volume
- 9
- Issue
- 391
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2619342418
- Cited by
- 256
- References
- 54
- FWCI
- 15.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.